{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T14:29:38Z","timestamp":1776781778073,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.oftal.2017.06.009","type":"journal-article","created":{"date-parts":[[2017,7,22]],"date-time":"2017-07-22T23:01:06Z","timestamp":1500764466000},"page":"147-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tub\u00e9rculo coroideo asintom\u00e1tico en un paciente con enfermedad de Crohn en tratamiento con adalimumab"],"prefix":"10.1016","volume":"93","author":[{"given":"V.M.","family":"Asensio-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"D\u00edaz-Cabanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mart\u00edn-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Haro-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2017.06.009_bib0055","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/jgh.12324","article-title":"Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: A Korean multicenter retrospective study","volume":"28","author":"Lee","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.oftal.2017.06.009_bib0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4166\/kjg.2013.61.5.270","article-title":"Clinical outcome of treatment with infliximab in Crohn's disease: A single-center experience","volume":"61","author":"Kim","year":"2013","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.oftal.2017.06.009_bib0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5414\/CP202705","article-title":"Post-authorization changes in the safety and efficacy assessment, recommended indications, and drug quality profile of adalimumab: A chronological overview","volume":"55","author":"Iv\u00e1nyi","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.oftal.2017.06.009_bib0070","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1128\/IAI.67.8.3980-3988.1999","article-title":"Early emergence of CD8+ T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice","volume":"67","author":"Serbina","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.oftal.2017.06.009_bib0075","unstructured":"World Health Organization. Global tuberculosis report 2014. Geneva: World Health Organization; 2014."},{"key":"10.1016\/j.oftal.2017.06.009_bib0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9394(00)00622-X","article-title":"Solitary nonreactive choroidal tuberculoma in a patient with acquired immune deficiency syndrome","volume":"131","author":"DiLoreto","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"5 Suppl 35","key":"10.1016\/j.oftal.2017.06.009_bib0085","first-page":"S14","article-title":"Overview of benefit\/risk of biological agents","volume":"22","author":"Imperato","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.oftal.2017.06.009_bib0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12348-014-0032-x","article-title":"Bilateral choroidal tuberculoma in miliary tuberculosis-report of a case","volume":"5","author":"Annamalai","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.oftal.2017.06.009_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2147\/IMCRJ.S119703","article-title":"Choroidal tuberculoma as a presenting sign of tuberculosis","volume":"9","author":"Arej","year":"2016","journal-title":"Int Med Case Rep J"},{"key":"10.1016\/j.oftal.2017.06.009_bib0100","doi-asserted-by":"crossref","first-page":"e012567","DOI":"10.1136\/bmjopen-2016-012567","article-title":"Risk of tuberculosis in patients treated with TNF-\u03b1 antagonists: A systematic review and meta-analysis of randomised controlled trials","author":"Zhang","year":"2017","journal-title":"BMJ Open"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117302046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669117302046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T05:52:46Z","timestamp":1602568366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669117302046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0365669117302046"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2017.06.009","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tub\u00e9rculo coroideo asintom\u00e1tico en un paciente con enfermedad de Crohn en tratamiento con adalimumab","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2017.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}